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Background: Cardiovascular Magnetic Resonance (CMR) enables non-invasive quantification of cardiac output (CO)
and thereby cardiac index (CI, CO indexed to body surface area). The aim of this study was to establish if CI
decreases with age and compare the values to CI for athletes and for patients with congestive heart failure (CHF).
Methods: CI was measured in 144 healthy volunteers (39 ± 16 years, range 21–81 years, 68 females), in 60 athletes
(29 ± 6 years, 30 females) and in 157 CHF patients with ejection fraction (EF) below 40% (60 ± 13 years, 33 females).
CI was calculated using aortic flow by velocity-encoded CMR and is presented as mean ± SD. Flow was validated
in vitro using a flow phantom and in 25 subjects with aorta and pulmonary flow measurements.
Results: There was a slight decrease of CI with age in healthy subjects (8 ml/min/m2 per year, r2 = 0.07, p = 0.001).
CI in males (3.2 ± 0.5 l/min/m2) and females (3.1 ± 0.4 l/min/m2) did not differ (p = 0.64). The mean± SD of CI in
healthy subjects in the age range of 20–29 was 3.3 ± 0.4 l/min/m2, in 30–39 years 3.3 ± 0.5 l/min/m2, in 40–49 years
3.1 ± 0.5 l/min/m2, 50–59 years 3.0 ± 0.4 l/min/m2 and >60 years 3.0 ± 0.4 l/min/m2. There was no difference in CI
between athletes and age-controlled healthy subjects but HR was lower and indexed SV higher in athletes. CI in
CHF patients (2.3 ± 0.6 l/min/m2) was lower compared to the healthy population (p< 0.001). There was a weak
correlation between CI and EF in CHF patients (r2 = 0.07, p< 0.001) but CI did not differ between patients with
NYHA-classes I-II compared to III-IV (n = 97, p = 0.16) or patients with or without hospitalization in the previous year
(n = 100, p = 0.72). In vitro phantom validation showed low bias (−0.8 ± 19.8 ml/s) and in vivo validation in 25
subjects also showed low bias (0.26 ± 0.61 l/min, QP/QS 1.04 ± 0.09) between pulmonary and aortic flow.
Conclusions: CI decreases in healthy subjects with age but does not differ between males and females. We found
no difference in CI between athletes and healthy subjects at rest but CI was lower in patients with congestive heart
failure. The presented values can be used as reference values for flow velocity mapping CMR.
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Cardiac output (CO) is one of the most important
physiological parameters as it directly and proportionally
reflects the metabolism of the entire organism. CO is
the sum of the systemic flow per minute and calculated
by the product of stroke volume and heart rate. The
ability of the body to adapt to increased workload and
hence metabolism is the result of the ability of the heart
to increase heart rate and stroke volume [1]. CO indexed
to body surface area (BSA) or cardiac index (CI), is an
important clinical parameter used in the assessment of
patients with heart disease as well as critically ill patients
and patients under anesthesia. CI is also of interest in
pharmacological studies [2] and the definition of forward
failure in patients with heart failure is a decrease in CI.
In clinical cardiology, cardiac output is determined when
quantifying intracardiac shunts and during right heart
catheterization to determine pulmonary resistance in
cases of pulmonary hypertension.
Most available methods for quantifying CI are hampered
by the invasive approach and/or the low accuracy and pre-
cision [2-6]. Invasive methods include Fick’s principle, ther-
modilution and dye dilution techniques and non-invasive
techniques Doppler measurements and bio-impedance.
Cardiovascular magnetic resonance (CMR) offers non-
invasive measurements of flow with high accuracy and pre-
cision [6,7] and CI can therefore be directly quantified
using aortic flow quantification. Previous CI reference
values for CMR are based on volumetry measurements but
no reference values for CMR using phase contract (PC)
flow velocity mapping has been presented.
Flow measurement is recommended in clinical CMR
protocols of patients with congenital and/or valvular
heart disease [8]. However, it is not known to what de-
gree CI is reduced in patients with heart failure or if ath-
letes show higher CI at rest compared to normal
subjects. Furthermore, the relationship between age and
CI in normal physiology is not fully established.
Therefore, the main aims of this study were to establish
if CI decreases with age and to compare CI in healthy sub-
jects to athletes and patients with heart failure. The pre-
sented CI values may also be used as reference values.
Methods
Patient population and study design
The study was approved by the local ethics committee.
Written informed consent was either obtained or waived
by the ethics committee. BSA was quantified according
to the Mosteller formula [9].
Healthy subjects
144 volunteers aged 21 to 81 years (39 ± 16 years,
68 females) were prospectively included in the study.
Age did not differ between females (38 ± 16 years) andmales (40 ± 15 years, p = 0.37). All subjects had a normal
electrocardiogram (ECG), no history of cardiovascular
disease, no cardioactive medication and a blood pressure
(BP) of ≤ 140/90 at the time of inclusion or at the time
of the magnetic resonance (MR) examination. All
healthy subjects had a BMI ≤ 30.
Athletes
60 professional athletes with high aerobic capacity (at
least 10 hours aerobic training per week) were prospect-
ively included. The athletes were active at a professional
level in triathlon, swimming, handball or soccer. Female
athletes (n = 30) and male athletes (n = 30) had the same
age range and mean± SD age,19-44 (29 ± 6) years. Age
and gender matched controls (n = 60) were selected for
comparison of CI between groups. The age and gender
distribution of athletes were: up to 29 years 15 males
and 25 females; 30–39 years 14 males and 5 females;
40–49 years 1 male.
Patients with heart failure (HF)
157 patients from the age of 24 to 86 years,
(60 ± 13 years, 33 females) with left ventricular ejection
fraction ≤ 40% were recruited retrospectively from
patients who had undergone CMR. Patients with more
than mild mitral regurgitation (>20% regurgitant frac-
tion), aortic regurgitation or aortic peak velocity
>3.0 m/s were not included. Available medical records
were reviewed and data was available in 97 patients on
New-York Heart Association (NYHA) classification [10]
and in 100 patients on the frequency of hospitalization
during the last year. The age and gender distribution of
patients were: up to 29 years 3 males and 2 females;
30–39 years 4 males and 5 females; 40–49 years 12 male
and 0 females, 50–59 years 42 males and 7 females;
above 60 years 63 males and 19 females.
CMR
All subjects were imaged in the supine position with
flow quantification of the ascending aorta during free
breathing. Two CMR-scanners were used, a) 1.5 T Mag-
netom Vision (Siemens, Erlangen, Germany) and b) Phi-
lips Achieva (Philips, Best, the Netherlands). Blood flow
was measured through a transversal plane at the height
of the pulmonary bifurcation perpendicular to the
ascending aorta with ECG-triggered phase-encoded
velocity-mapping sequences. Typical imaging parameters
for Siemens Vision were: echo time 5 ms, slice thickness
8 mm, velocity encoding factor 150 cm/s, time reso-
lution typically 40 ms and gradient strength 25mT/m.
Velocity information was acquired by prospective ECG-
triggering. Typical imaging parameters for Philips
Achieva were: echo time 6 ms, slices thickness 6 mm,
velocity encoding 200 cm/s, time resolution typically
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gradients for Philips Achieva was set to “regular mode”
imposing limits on the maximal gradient strength and
slew rate used. A detailed description of the velocity
mapping technique has been published previously
[11,12]. Cine images of the left ventricle was performed
in the short axis view for left ventricular function.
In vitro and in vivo validation
All in vitro and in vivo validation were performed at the
Philips Achieva scanner as we previously have per-
formed and published phantom and in vivo validation
for the Siemens scanner [7]. A flow phantom composed
of two plastic tubes, connected to give flow in both
directions simultaneously, was used. The tubes were sur-
rounded by static material. Water, doped with the clinic-
ally used contrast agent, was pumped through the tubes
at four different flow rates and was assessed with the
same flow quantification sequence as used for the
in vivo data. Timer and beaker quantification of flow
was used as reference. Aortic and pulmonary flows were
measured for in vivo validation in 25 subjects and bias
according to Bland-Altman were calculated.
Image analysis
The ascending aorta was outlined in the anatomic images
for each time point with flow calculation performed inFigure 1 CMR quantification of cardiac output. The modulus
image (A) is used for anatomical delineation of the aorta (black
circle) and measurement is performed in the corresponding phase
image (B). Cardiac output can be calculated by quantifying stroke
volume as the integral of the resulting flow curve (C) and
multiplying with heart rate.the corresponding velocity-encoded phase images
(Figure 1). The average flow velocity (cm/s) was multi-
plied by the area of the vessel (cm2) to obtain flow (ml/s)
at each time point. Flow throughout the cardiac cycle
was integrated over one cardiac cycle to obtain the stroke
volume (SV). Cardiac output (CO) was determined as SV
multiplied by heart rate (SV•HR), and Cardiac index (CI),
as CO divided by body surface area (BSA).
Flow was measured using Segment 1.4 (http://segment.
heiberg.se) [13]. Two independent observers analyzed
the flow data from 20 controls to calculate interobserver
variability. Ejection fraction was calculated for all patients
using manual outlining of the endocardial contours in
the end-diastolic and end-systolic phases.Statistical analysis
GraphPad Prism 5.02 (GraphPad Software Inc.) was used
for statistical calculations. Continuous variables are pre-
sented as mean ± SD. Limits of agreement defined as the
mean ± 2SD for CI was calculated within each age group.
The Mann–Whitney test was used to differentiate be-
tween CI, HR and SV in healthy subjects and patients
with HF and athletes as well as between male and
females and CI at different age groups. Two-way
ANOVA was used to analyze variations in CI due to age
and gender. Linear regression analysis was performed
for CI, HR and SV vs. age and CI vs. ejection fraction as
well as for the in vitro experiments. CI in patients with
different NYHA class (I-II vs. III-IV) and the need for
hospitalization the previous year was compared using
the Mann–Whitney test. Interobserver variability,
in vivo and in vitro validation were calculated accordingFigure 2 Cardiac index in healthy subjects declined with age
similarily in males (open squares) and females (filled circles).
The linear regression lines are shown in solid lines and the 95%
confidence interval with broken lines. The relationship between CI
and age was similar in males (y =−0.0095age + 3.275, r2 = 0.08,
p = 0.02) and females (y =−0.0072age+ 3.423, r2 = 0.08, p = 0.02).
Table 1 Cardiac index and age adjusted reference values
Age (years) Males (n) Females (n) CI (l/min/m2) Reference values p vs. CI of −29 years
−29 25 30 3.3 ± 0.4 2.5-4.1 NA
30-39 20 12 3.3 ± 0.5 2.3-4.3 ns.
40-49 8 10 3.1 ± 0.5 2.1-4.1 ns.
50-59 13 9 3.0 ± 0.4 2.2-3.8 <0.001
60- 10 7 3.0 ± 0.4 2.2-3.8 0.007
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Results
Cardiac index in healthy subjects
Cardiac index in healthy subjects did not differ between
males (3.2 ± 0.5 l/min/m2) and females (3.1 ± 0.4 l/min/
m2, p = 0.64) but there was a slight decrease of CI with
age (8 ml/min/m2 per year, r2 = 0.07, CI =−0.008xage +
3.511, p = 0.001), Figure 2. Similarly, age (p = 0.01) but
not gender (p = 0.57) was a significant variable for CI in
the two-way ANOVA analysis. The slight decrease of CI
with age was explained by a decrease in SV with age
(r2 = 0.06, SV=−0.27xage + 106.4, p = 0.004). Heart rate
did not change with age (p = 0.87). The mean± SD of CI
and limits of agreement for healthy subjects according
to age and gender is listed in Table 1. The minimum CI
found in an individual was 2.3 l/min/m2. The interobser-
ver variability of cardiac output measurements was
0.2 ± 0.2 l/min or 3 ± 4%.Figure 3 There were no significant differences in cardiac index
of male and female athletes compared to age and gender
matched controls. One outlier in the male athlete group was seen
and the stroke volume (174 ml) and heart rate (68/min) were
confirmed on cine-CMR.Cardiac index in athletes vs. healthy subjects
Cardiac index in female (3.4 ± 0.6 l/min/m2) and male
athletes (3.7 ± 0.6 l/min/m2) did not differ significantly
(p = 0.09, Figure 3). There was no difference in CI be-
tween athletes and age-matched healthy subjects in ei-
ther females (p = 0.20) or males (p = 0.07). Athletes had
higher stroke volume index quantified on PC-CMR
(66 ± 7 ml/m2 for males and 60 ± 9 ml/m2 for females)
compared to age and gender matched healthy subjects
(54 ± 6 ml/m2 for males and 50 ± 7 ml/m2 for females,
p< 0.001 for both). On the other hand, heart rates were
lower in athletes (males 56±7/min and females 58±9/min)
compared to controls (males 64±10/min and females
64±12/min, p=0.003 and p=0.01, respectively).
Cardiac index in patients vs. healthy subjects
CI in patients with congestive heart failure (2.3 ± 0.6 l/
min/m2) was lower compared to the healthy population
(3.2 ± 0.5 l/min/m2, p< 0.001), although there was a
large overlap (Figure 4) with 49% of patients´ CI within
mean ± 2SD of healthy subjects´ CI. Patients had a
lower effective SV index (32 ± 9 ml/m2) compared to
healthy subjects (51 ± 7 ml/m2, p< 0.001) and higher
heart rate (73 ± 15/min and 64 ± 9/min respectively,
p< 0.001). The subset of patients with normal CI had
lower SV index (36 ± 7 ml/m2, p< 0.001) and higher
heart rate (76 ± 15, p< 0.001) compared to healthyFigure 4 Cardiac index in patients were lower compared to
healthy subjects (*** p< 0.001) although there was a large overlap.
Figure 5 There was a weak correlation of cardiac index with
ejection fraction.
Figure 7 Flow data from in vitro phantom experiments showed
an excellent correlation between flow measured with timer and
beaker and CMR.
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patients with decreased CI (28 ± 8 ml/m2, p< 0.001 and
70 ± 15/min, p = 0.006, respectively). In patients, CI had a
weak relationship with decreasing EF (r2 = 0.07,
p< 0.001, equation CI = 0.02xEF + 1.7), Figure 5. There
was no significant correlation with age in the patient
population (r2 = 0.004, p = 0.56). Cardiac index did not
differ between NYHA-classes I-II (2.3 ± 0.5 l/min/m2)
and NYHA classes III-IV (2.2 ± 0.6 l/min/m2, p = 0.16),
Figure 6. Neither did CI differ in patients with hospitali-
zations the previous year (2.2 ± 0.5 l/min/m2) vs. patients
without hospitalizations (2.3 ± 0.6 l/min/m2, p = 0.72).In vitro and in vivo validation
Phantom measurements showed an excellent correlation
(r2 = 1.00, y = 1.08x + 0.79, p< 0.001) and Bland-AltmanFigure 6 Patients with NYHA class III and IV did not have lower
CI compared to patients with NYHA class I and II (p = 0.16). CI
of healthy subjects are showed for comparison.analysis showed a low bias (−0.8 ± 19.8 ml/s) between
flow as measured by timer and beaker and by MR,
Figure 7. The bias according to Bland-Altman analysis
between pulmonary and aortic flow was 0.26 ± 0.61 l/min
or 4 ± 8%. This results in a QP/QS of 1.04 ± 0.09.
Discussion
This study has confirmed that CI decreases with age,
probably caused by a decreased level of metabolism.
There were no differences between CI in males and
females in healthy subjects and athletes had similar CI
values to healthy subjects. CI was found to be lower in
patients with heart failure compared to healthy subjects,
although 49% of the heart failure patients fall within the
normal ranges of CI. Finally, there was a weak correl-
ation of CI and EF but no differences were found in CI
between patients with NYHA-class I-II and III-IV or the
absence/presence of hospitalization during the last year.
Normal CI values and variation with age
This study showed a decrease of CI with age (8 ml/min/
m2) which is in line with lower stroke volumes in older
subjects found in reference values of cine CMR [14,15].
Metabolism decreases with age, especially in sedentary
individuals [16,17] and this is the most likely explanation
to the decrease for CI with age. We did not find any
gender difference in CI which is in line with our previ-
ously published normal values for gradient-echo cine
CMR images [15] where no gender differences were seen
in SV adjusted for BSA. Maceira et al., however, did find
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females [14]. The difference between our studies are not
clear and further studies in other cohorts comparing SV
and CI between gender would therefore be of interest.
The mean CI values in this study, 3.1 l/min/m2 for
women and 3.2 l/min/m2 for men, are the same mean
values previously described by our group [7].Cardiac index in athletes
CI at rest was found to be similar in athletes and sub-
jects with regular exercise levels already in the 1960´s
using invasive techniques [1] but this is the first study to
show that the same reference values can be used for CI
in athletes as for other healthy subjects. The lack of a
difference in CI between normals and elite athletes
underscores that cardiac CI is primarily dependent on
the basal metabolism. The higher SV and lower HR in
athletes compared to controls reiterates the higher re-
serve capacity for increasing CI through HR increase
during stress in athletes. Even if there are no differences
in CI between healthy volunteers and elite athletes at
rest, the differences become clear during exercise [1].
The main difference induced by training is that stroke
volume at peak exertion increases [18]. This is in line
with the findings from our previous CMR study of 60
healthy volunteers and 71 elite athletes demonstrating
that VO2max is proportional to total heart volume [19].
The larger total heart volumes in athletes results in a
possibility of generating larger cardiac output due to
higher stroke volume at similar heart rate.Cardiac index in heart failure
Half of the patients had CI within normal limits and this
was obtained through a higher heart rate although stroke
volume was decreased compared to healthy subjects. The
finding that 49% of the patients with heart failure were
within normal limits of CI at rest shows that CI on its
own is not useful as an indicator of heart failure in
patients that fall within normal limits. An earlier study
has suggested a method to differentiate these patients
from healthy subjects by relating VO2max to total heart
volume (THV) [20]. In that study, patients with
increased THV fell below normal subjects in VO2max
capacity.
Quantification of CI is primarily performed in the
clinical management of heart failure when assessing
pulmonary vascular resistance and shunt lesions. Medi-
cation of heart failure often aims to increase the CI and
CMR could play an important role when assessing new
therapies for heart failure. The high accuracy with
CMR would lower the number needed for detection of
therapeutic effect.Measurements of CI with CMR
Flow quantification with PC-CMR has been extensively vali-
dated and found to have high accuracy in large [7,21-23]
and small [24,25] vessels. Studies with segmented
sequences in modern scanners with shorter bore have
shown problems with phase offsets thay may cause errors
in CI measurements PC-CMR [26,27]. The baseline shifts
caused by phase offsets can be corrected for by dedicated
post-processing or by using phantoms [28]. The transversal
image plane for aortic flow used in our study have lower
phase offset compared to oblique image planes more prox-
imal to the aortic valve [27]. The CI quantification in this
study was done using a non-segmented sequence during
free breathing and with the use of a lower gradient
mode. Restricting the gradient strength can help to de-
crease the phase-shift errors (personal communication
Dr. M Kouwenhoven, Philips Healthcare, Best, the Nether-
lands) and the flow results from the validations in this
study in phantoms and in vivo showed low bias within the
physiological range. Of note, the in vivo validation found a
mean QP/QS of 1.04 which is the expected value taking
into account a coronary artery flow of 3-5% of cardiac
output.Limitations
This study was performed in a single center using two
different scanners from different vendors. Full medical
records could not be obtained in all patients and there-
fore not all patients were included in the analysis for a
possible relationship between CI and NYHA class and
presence of hospitalization. Examinations in a CMR
scanner may cause psychological stress due to the con-
fined space and examination in a hospital setting. This
may have resulted in a higher CI values compared to the
CI at complete rest at home.Conclusions
CI over a wide age range in healthy subjects are pre-
sented and can be used as reference values for CMR. CI
decreases in healthy subjects with age but does not differ
between males and females. We found no difference in
CI between athletes and healthy subjects but CI was
lower in patients with congestive heart failure.Competing interests
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